StockData
Puma Biotechnology, Inc. logo

Puma Biotechnology, Inc. (PBYI) stock

PBYINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/3019% below fair value
$7.22+0.08 (+1.12%)

Close on Nov 18, 2026Market cap $372.70MP/E 13.9Yield –

Puma Biotechnology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Puma Biotechnology's price to book ratio was 3.0× on Nov 11, 2026, against 2.2× a year earlier. Over the last 5 years it ranged from 1.6× to 22.7×, with a median of 3.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.0×+0.4
2025Dec 31, 20252.6×+0.5
2024Dec 31, 20242.1×−3.2
2023Dec 29, 20235.3×−3.4
2022Dec 30, 20228.7×+1.7
2021Oct 29, 20217.0×−7.1
2020Oct 30, 202014.2×−5.7
2019Dec 31, 201919.8×+2.9
2018Dec 31, 201816.9×−29.8
2017Dec 29, 201746.7×+35.7
2016Dec 30, 201610.9×+0.6
2015Dec 31, 201510.4×−29.9
2014Dec 31, 201440.3×+8.9
2013Dec 31, 201331.3×−10.4
2012Dec 31, 201241.7×–

More Puma Biotechnology figures

See a number that looks wrong?